Home › Post-COVID Conditions (Long COVID) › Virginia
Post-COVID Conditions (Long COVID) clinical trials in Virginia
6 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Virginia.
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Velocity Clinical Research - Hampton ( Site 3744), Hampton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Charlottesville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Velocity Clinical Research, Suffolk, Suffolk
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Charlottesville
- GSK Investigational Site, Newport News
RecruitingPhase 1
Ages 65 to 85 · All sexes · Updated Jun 30, 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- VCU Health System, Richmond
RecruitingPhase 3
All ages · All sexes · Updated Jun 23, 2026 · NCT03808922A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- Richard Bennett - Clinical Research Partners, Richmond
RecruitingPhase 4Healthy volunteers welcome
6 Months · All sexes · Updated Mar 27, 2026 · NCT06585241From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.